Signaling Pathways
Signaling Pathways(信号通路)
- Proteases(63)
- Apoptosis(1190)
- Chromatin/Epigenetics(17)
- Metabolism(420)
- MAPK Signaling(32)
- Tyrosine Kinase(97)
- DNA Damage/DNA Repair(62)
- PI3K/Akt/mTOR Signaling(56)
- Microbiology & Virology(68)
- Cell Cycle/Checkpoint(205)
- Ubiquitination/ Proteasome(43)
- JAK/STAT Signaling(13)
- TGF-β / Smad Signaling(30)
- Angiogenesis(85)
- GPCR/G protein(3)
- Stem Cell(27)
- Membrane Transporter/Ion Channel(273)
- Cancer Biology(514)
- Endocrinology and Hormones(168)
- Neuroscience(462)
- Obesity, Appetite Control & Diabetes(9)
- Peptide Inhibitors and Substrate(1)
- Other Signal Transduction(141)
- Immunology/Inflammation(1111)
- Cardiovascular(63)
- Vitamin D Related
- Antibody-drug Conjugate/ADC Related
- PROTAC(254)
- Ox Stress Reagents(25)
- Others(1718)
- Antiparasitics(21)
- Toxins(90)
Signaling Pathways 相关产品(35130)
- GC12419UNC 926 hydrochlorideCAS: 1184136-10-4纯度: >98.00%
An antagonist of L3MBTL1, L3MBTL3, and L3MBTL4
- GC12422ABT-888 (Veliparib)CAS: 912444-00-9纯度: >99.50% / >98.00%
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂，Ki分别为5.2和2.9nM。
- GC12475NSC 632839 hydrochlorideCAS: 157654-67-6纯度: >98.50%
A deubiquitylase and deSUMOylase inhibitor
- GC12482BRAF inhibitorCAS: 918505-61-0纯度: >98.50%
BRAF 抑制剂是从专利 WO/2011103196 A1 化合物 P-0850 中提取的 B-Raf 抑制剂。
- GC12483Eribulin mesylateCAS: 441045-17-6纯度: >99.00%
Eribulin mesylate (E7389 mesylate) 是一种微管靶向剂，用于研究转移性乳腺癌。甲磺酸艾日布林通过结合微管蛋白和微管来抑制癌细胞的增殖。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC12410 | Bupivacaine HCl | 18010-40-7 | >98.00% / >99.50% | |
An Analytical Reference Standard | ||||
| GC12419 | UNC 926 hydrochloride | 1184136-10-4 | >98.00% | |
An antagonist of L3MBTL1, L3MBTL3, and L3MBTL4 | ||||
| GC12422 | ABT-888 (Veliparib) | 912444-00-9 | >99.50% / >98.00% | |
ABT-888 (Veliparib)是一种有效的PARP1和PARP2抑制剂，Ki分别为5.2和2.9nM。 | ||||
| GC12427 | 8-Hydroxy-PIPAT oxalate | 159651-91-9 | - | |
5-HT1A receptor agonist | ||||
| GC12429 | AY 9944 dihydrochloride | 366-93-8 | >99.50% / >98.00% | |
A cholesterol synthesis inhibitor | ||||
| GC12430 | FH1(BRD-K4477) | 2719-05-3 | - | |
A small molecule promotor of hepatocyte differentiation | ||||
| GC12434 | AZD1981 | 802904-66-1 | >99.50% | |
A DP 2 /CRTH 2 receptor antagonist | ||||
| GC12436 | Org 25543 hydrochloride | 495076-64-7 | - | |
GlyT2抑制剂 | ||||
| GC12438 | AZD-5438 | 602306-29-6 | >99.50% | |
A potent inhibitor of CDKs | ||||
| GC12442 | Strontium chloride | 10476-85-4 | >99.00% | |
Calcium sensing receptor (CaSR) agonist | ||||
| GC12443 | Tranilast Sodium | 104931-56-8 | - | |
An antiallergic agent | ||||
| GC12444 | Clemizole | 442-52-4 | - | |
An antihistamine and TRPC5 channel blocker | ||||
| GC12453 | Succinylcholine Chloride Dihydrate | 6101-15-1 | - | |
An agonist of muscle-type nAChRs | ||||
| GC12454 | BMS-911543 | 1271022-90-2 | - | |
A potent, selective JAK2 inhibitor | ||||
| GC12467 | KPT-330 | 1393477-72-9 | >98.00% | |
KPT-330（Selinexor）是一种具有口服活性的选择性核输出抑制剂（SINE）化合物，抑制核输出蛋白XPO1（又名CRM1）。 | ||||
| GC12468 | Timolol Maleate | 26921-17-5 | >99.50% | |
A non-selective β-adrenergic receptor antagonist | ||||
| GC12470 | ZCL278 | 587841-73-4 | >98.00% | |
A selective Cdc42 inhibitor | ||||
| GC12475 | NSC 632839 hydrochloride | 157654-67-6 | >98.50% | |
A deubiquitylase and deSUMOylase inhibitor | ||||
| GC12478 | ARRY-380 | 937265-83-3 | - | |
An inhibitor of EGFR | ||||
| GC12482 | BRAF inhibitor | 918505-61-0 | >98.50% | |
BRAF 抑制剂是从专利 WO/2011103196 A1 化合物 P-0850 中提取的 B-Raf 抑制剂。 | ||||
| GC12483 | Eribulin mesylate | 441045-17-6 | >99.00% | |
Eribulin mesylate (E7389 mesylate) 是一种微管靶向剂，用于研究转移性乳腺癌。甲磺酸艾日布林通过结合微管蛋白和微管来抑制癌细胞的增殖。 | ||||
| GC12489 | Ivacaftor benzenesulfonate | 1134822-09-5 | - | |
A CFTR potentiator | ||||
| GC12491 | Narciclasine | 29477-83-6 | >99.50% | |
Narciclasine是一种具有抗有丝分裂和促凋亡活性的植物生长调节剂。 | ||||
| GC12495 | Olanzapine | 132539-06-1 | >99.00% / >98.00% / >99.50% | |
Olanzapine是一种单胺拮抗剂。 | ||||